Cited by 48Diabetes Management and ResearchPancreatic function and diabetesDiabetes and associated disorders

The year of transition from research to clinical practice

Kovatchev, Boris·2018·Nature Reviews Endocrinology

Integrity signals

Registry

Crossref · 10.1038/nrendo.2017.170

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Using CGM within hybrid closed-loop pump systems that set basal insulin automatically but need users to deliver meal boluses manually leads to large gains in glucose variability and overall glycaemic control.

    “When CGM is incorporated into hybrid closed-loop insulin-pump systems that automatically regulate basal infusion rates, but that require manual delivery of meal boluses by trained wearers to cover estimated carbohydrate intakes, substantial improvements in glucose variability and overall glycaemic control are seen (figure 5).93”

    From Type 1 diabetes (2018) · cites this paper as [93]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kovatchev, B.
Affiliations
University of Virginia (US)
Corresponding author
Kovatchev, Boris
Venue
Nature Reviews Endocrinology
Published
2017-12-22
Volume
14
Issue
2
Pages
74-76
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W2776497160
Cited by
48
References
9
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 8 · 2018: 8
FWCI
5.18
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
artificial pancreas, diabetes mellitus, type 1 diabetes, insulin pump, clinical trials, commercialization
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Pancreas, Artificial, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review